Ceribell (CBLL) Debt Ratio (2024 - 2026)

Ceribell (CBLL) posted Debt Ratio of 0.11 for Q1 2026, up 10.54% on a QoQ basis from 0.1 in Q4 2025, and up 21.7% year-over-year from 0.09 in Q1 2025.

Ceribell (CBLL) Debt Ratio (2024 - 2026) Analysis & Trends

Ceribell's Debt Ratio history runs 3 years deep, the most recent figure standing at 0.11 for Q1 2026.

  • Quarterly Debt Ratio rose 21.7% year-over-year to 0.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.11 (up 21.7% YoY) and the FY2025 annual result came in at 0.1, up 16.61% from the prior year.
  • Debt Ratio was 0.11 for Q1 2026 at Ceribell, up from 0.1 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.41 in Q3 2024 and bottomed at 0.09 in Q4 2024.
  • A 3-year average of 0.14 and a median of 0.1 in 2025 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2025 — Debt Ratio slumped 76.11% — and 2026, when it climbed 21.7%.
  • Ceribell's Debt Ratio stood at 0.09 in 2024, then increased by 16.61% to 0.1 in 2025, then rose by 10.54% to 0.11 in 2026.
  • Business Quant data shows CBLL's Debt Ratio at 0.11 in Q1 2026, 0.1 in Q4 2025, and 0.1 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 0.31
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 0.32
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 0.30
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 0.04
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 0.27
8 Smith & Nephew 26.99 Bn 26.41 Bn - 0.30
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 0.30
10 Ceribell 677.56 Mn 536.38 Mn 23.12 Mn 0.11

Historic Data

Download Data
DateValue
Mar 31, 2026 0.11
Dec 31, 2025 0.10
Sep 30, 2025 0.10
Jun 30, 2025 0.09
Mar 31, 2025 0.09
Dec 31, 2024 0.09
Sep 30, 2024 0.41